pCPA File Number: 22352
To decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive antineoplastic drug.
Apobiologix, a Division of Apotex Inc.
CADTH Project Number:
pCPA Engagement Letter Issued:
Negotiation Process Concluded: